ProMetic Life Sciences Inc. (PFSCF: OTCQX International) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ProMetic Life Sciences Inc. (PFSCF: OTCQX International) | ProMetic to Commercially Launch Fibrinogen in the Fourth Quarter of 2014 ProMetic to Commercially Launch Fibrinogen in the Fourth Quarter of 2014

ProMetic to Commercially Launch Fibrinogen in the Fourth Quarter of 2014

LAVAL, QUEBEC--(Marketwired - Jul 10, 2014) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that it will launch fibrinogen for commercial sales during the fourth quarter of 2014 after its successful scale-up at its Laval based plasma purification facility, ProMetic BioProduction Inc. ("PBP"). This follows the previously disclosed proteins already scheduled for production at PBP, namely plasminogen, IVIG and Alpha-1 Antitrypsin.

Sales of fibrinogen manufactured at commercial scale to pharmaceutical companies as a GMP product will be starting in the fourth quarter of 2014, 6 months ahead of the originally anticipated timeline. The fibrinogen protein has many commercial applications ranging from harvesting and culturing stem cells to use in wound healing products, hemostatic bandages and drug delivery systems. The worldwide market for fibrinogen exceeds $500 million per year. The Corporation is already in discussion with potential users of the product about making initial supplies in the fourth quarter of 2014.

"There is a growing market for fibrinogen used in various commercial applications that do not require regulatory authorization and we expect revenue contribution to start as soon as the fourth quarter 2014", said Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic who also added "We are also considering a clinical regulatory pathway to support the use of fibrinogen for specific rare and unmet medical conditions".

ProMetic's proprietary and proven PPPS™ platform has consistently delivered higher recovery yield for several proteins, including fibrinogen which has a production yield exceeding double that of the industry average. Prometic is also further leveraging its PPPS™ platform to enable the manufacturing of two other orphan drugs in 2014.

About Fibrinogen

Fibrinogen, also called Factor I, is a blood plasma protein produced by the liver that plays an important role in blood coagulation. Blood coagulation is a process in which several components of the blood form a clot. When blood escapes from a rupture in a blood vessel, coagulation is triggered. Several proteins, called coagulation factors, go into action to produce thrombin. The thrombin then converts fibrinogen to fibrin. Fibrin produced from fibrinogen is the main protein in a blood clot. It surrounds the cells in the blood and plasma and helps form the clot. The resulting clot, which is stabilized by Factor XIII, remains intact from 10 to 14 days, the time required for healing to take place.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ( www.prometic.com ) is a long established biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, cancer and autoimmune diseases/inflammation. Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe and Asia.

Forward Looking Statements

This press release contains forward-looking statements about ProMetic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations in ProMetic's Annual Information Form for the year ended December 31, 2013, under the heading "Risk and Uncertainties related to ProMetic's business". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if new information becomes available, as a result of future events or for any other reason, unless required by applicable securities laws and regulations. All amounts are in Canadian dollars unless indicated otherwise.

Pierre Laurin
President and CEO
ProMetic Life Sciences Inc.
p.laurin@prometic.com
+1.450.781.0115
Frederic Dumais
Director, Communications and
Investor Relations
ProMetic Life Sciences
f.dumais@prometic.com
+1.450.781.0115

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 110

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 121

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 100

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 108

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Global Gifts Retailing Market

Updated Category News Views 120

The Gifts Retailing Market is Evolving Rapidly The global gifts retailing industry is projected to experience substantial growth, with estimates indicating an increase of USD 11.01 billion from 2024 to 2028. Several influential factors are driving this trend, notably the rising demand for seasonal decorations and a stronger gifting culture. As consumers increasingly...

Continue Reading
Exploring the Risks Behind the Monumental Rise of Big Tech

Updated Category News Views 163

Understanding the Current Landscape of Big Tech Investment In recent discussions about the tech industry, significant concerns have bubbled to the surface regarding the sustainability of current market valuations. Analysts have pointed out that the optimism surrounding the surge in equity prices may be fueled by unrealistic expectations. John Hussman notably remarked on...

Continue Reading
Senator Markwayne Mullin Makes Notable Stock Purchase in LPL

Updated Category News Views 246

Senator Markwayne Mullin's Recent Stock Transactions Recent financial disclosures reveal that Senator Markwayne Mullin has made a significant investment in LPL Financial Holdings Inc (NASDAQ: LPLA). The purchase, valued between $233,016 and $670,000, was filed recently and adds to his active trading portfolio. This transaction indicates Mullin's ongoing interest in the...

Continue Reading
Pathward Financial: Sale of Insurance Business Extended

Updated Category News Views 123

Pathward Financial, Inc. (NASDAQ: CASH), known as Meta Financial Group in the past, extended the closing of its commercial insurance premium finance business sale to October 22, from an initial deadline of October 1. Traders were quick to sniff out that this delay wasn’t just a minor hiccup—it pointed to deeper operational challenges. Delays and What They Mean for...

Continue Reading
Vallourec's Major Supply Order from ADNOC Signals Growth

Updated Category News Views 198

Vallourec's Major Supply Agreement with ADNOC Vallourec, a global leader in premium seamless tubular solutions, has successfully secured a significant order from the Abu Dhabi National Oil Company (ADNOC). This order includes supplying over 30,000 tons of carbon steel tubulars and related accessories, prominently featuring VAM premium connections. This transaction forms...

Continue Reading